Applegate II, Richard L. http://orcid.org/0000-0002-1454-4549
Applegate, Patricia M.
Cannesson, Maxime
Peiris, Prith
Ladlie, Beth L.
Torp, Klaus
Funding for this research was provided by:
Masimo
Article History
Received: 3 October 2019
Accepted: 20 November 2019
First Online: 3 December 2019
Change Date: 31 July 2020
Change Type: Correction
Change Details: In the original publication of the article, the ABGHb graph of Fig. 2 was incorrectly rendered during conversion from black and white to color. The figure shows hemoglobin results from the 3 compared monitoring methods to results obtained by laboratory hematology analyzer. Importantly this illustration of secondary outcome was not used for statistical comparisons but is intended to show relative accuracy of the 3 monitoring methods. The corrected Fig. 2 is given in this erratum.
Compliance with ethical standards
:
: PP, BL, and PMA have nothing to disclose. RLA, MC and KT disclose each has been principal investigator in studies for which the Departments of Anesthesiology at their institutions received funding from Masimo Corporation and have served as consultants to Masimo Corporation scientific advisory boards. Dr. Torp holds regular shares in Masimo in an amount of less than $50,000. Dr. Cannesson is a consultant for Edwards Lifesciences and Masimo Corp, and has funded research from Edwards Lifesciences and Masimo Corp. He is also the founder of Sironis owns patents and receive royalties for closed loop hemodynamic management that have been licensed to Edwards Lifesciences. Dr. Cannesson’s Department receives funding from the NIH (R01GM117622; R01 NR013012; U54HL119893; 1R01HL144692).